Shandong Yixiang Group is located in the beautiful peony city of Heze, with two pharmaceutical companies under its jurisdiction: Heze Yulong Biotechnology Co., Ltd. and Shandong Yixiang Pharmaceutical Co., Ltd. Yulong Biological covers an area of more than 30 mu, mainly producing Cefotaxime sodium, Cefotaxime acid, Amoxicillin, Amoxicillin sodium, benzathine Cloxacillin, Cloxacillin sodium, ampicillin sodium, tilmicosin phosphate and other veterinary raw materials and intermediates. After more than 10 years of deep cultivation, the company has won a good reputation at home and abroad, and is well received by customers. The company has gradually developed into a large local taxpayer. With more and more high-quality customers, The order volume is increasing, and the production capacity of Yulongnian is no longer able to meet customer needs. In order to better meet market needs and lead the development of veterinary raw materials, the group invested in the construction of Shandong Yixiang Pharmaceutical Co., Ltd. in 2021, and completed and officially put into operation in early 2023. Yixiang covers an area of more than 100 acres, has three modern GMP production workshops, with a total investment of 150 million yuan, and an annual production capacity of over 1500 tons. The company has more than 10 high-precision and cutting-edge scientific research personnel, equipped with independent laboratories and R&D teams, and cutting-edge equipment testing instruments, More than 40% of company employees have a bachelor's degree or above. Yixiang Pharmaceutical is a key enterprise in the province, and is a key project signed by the "Dialogue Business Association, Qilu Agreement" in the province. The company's products are market-oriented, and after years of stable development, it has multiple sales and service teams, with foreign customers in more than 20 countries around the world.